Abiopharma

🔍 HACKETT ANN F (Executive)

Company: Fortune Brands Innovations, Inc. (FBIN)

Report Date: 2026-05-05

Detailed Transactions and Holdings:

• Acquired 4,191 shares of Common Stock, Par Value $0.01 (Direct)
  Date: 2026-05-05 | Code: A | equity_swap_involved: false | shares_owned_after: 41,931.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: Reflects a grant of stock under the Company's Long-Term Incentive Plan.
• F2: Includes 34,815 shares of common stock, receipt of which was deferred until the January following the calendar year in which Ms. Hackett ceases to be a member of the Board of Directors.